You just read:

New Phase 2 Data Show Stelara® (Ustekinumab) Sustained Improvement In Disease Activity In Adults With Systemic Lupus Erythematosus Through One Year

News provided by

Janssen Pharmaceutical Companies of Johnson & Johnson

Oct 23, 2018, 08:07 ET